Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
22 Setembro 2021 - 3:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: August 2021
Commission File Number: 000-51848
Avricore Health Inc.
(Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
3500 – 1055 Dunsmuir Street PO Box 49114 Vancouver BC V7X1H7
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F x Form 40-F o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes o No x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes o No x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No x
Exhibits
The following exhibits are included in this Form 6-K:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: September 21, 2021
|
AVRICORE HEALTH INC.
|
|
|
|
By: /s/ Kiki Smith
|
|
Kiki Smith
|
|
Chief Financial Officer
|
2
Avricore Health (QB) (USOTC:AVCRF)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Avricore Health (QB) (USOTC:AVCRF)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Avricore Health Inc (QB) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Avricore Health Inc.